« Back
Home /
Botensilimab

Botensilimab

€895.00

Excl. VAT

Item no.	HY-P99484-5mg
Manufacturer	MedChem Express
CASRN	2408310-37-0
Amount	5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitor
Specific against	other
Purity	97.18
Dry ice	Yes
Citations	[1]Delepine C, et, al. 470 Botensilimab, an Fc-enhanced CTLA-4 antibody, enhances innate and adaptive immune activation to promote superior anti-tumor immunity in cold and I-O refractory tumors FREE.
Smiles	[Botensilimab]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	AGEN 1181
Available
Product Description	Botensilimab (AGEN 1181), a humanized anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer[1].
StorageTemperature	Store at -80°C for 2 years
Shipping	Dry Ice
Molecular Weight	N/A
Clinical Information	Phase 2
Solubility	H2O
Pathway	Immunology/Inflammation
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

Listprice: €895.00

Price: €895.00

available

Quantity:

Compare

Add to wishlist